These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31481446)

  • 1. Anti-HIV and Anti-Hepatitis C Virus Drugs Inhibit P-Glycoprotein Efflux Activity in Caco-2 Cells and Precision-Cut Rat and Human Intestinal Slices.
    Martinec O; Huliciak M; Staud F; Cecka F; Vokral I; Cerveny L
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Potency of Anti-HIV and Anti-HCV Drugs to Inhibit P-Glycoprotein Mediated Efflux of Digoxin in Caco-2 Cell Line and Human Precision-Cut Intestinal Slices.
    Huličiak M; Vokřál I; Holas O; Martinec O; Štaud F; Červený L
    Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of drug efflux and uptake transporters in atazanavir intestinal permeability and drug-drug interactions.
    Kis O; Zastre JA; Hoque MT; Walmsley SL; Bendayan R
    Pharm Res; 2013 Apr; 30(4):1050-64. PubMed ID: 23224979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV protease inhibitors: garlic supplements and first-pass intestinal metabolism impact on the therapeutic efficacy.
    Berginc K; Trdan T; Trontelj J; Kristl A
    Biopharm Drug Dispos; 2010 Nov; 31(8-9):495-505. PubMed ID: 21104925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of P-glycoprotein and Cotreatment with Sofosbuvir on the Intestinal Permeation of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Fumarate.
    Huliciak M; Lhotska I; Kocova-Vlckova H; Halodova V; Dusek T; Cecka F; Staud F; Vokral I; Cerveny L
    Pharm Res; 2023 Sep; 40(9):2109-2120. PubMed ID: 37594591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
    Profit L; Eagling VA; Back DJ
    AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers.
    Alsenz J; Steffen H; Alex R
    Pharm Res; 1998 Mar; 15(3):423-8. PubMed ID: 9563072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Mathematical simulation to explain the coordinated functions of efflux and metabolism limiting the transport of anti-HIV agents across Caco-2 cells.
    Patel J; Hussain A; Pal D; Mitra AK
    Am J Ther; 2004; 11(2):114-23. PubMed ID: 14999363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interindividual variability in the effect of atazanavir and saquinavir on the expression of lymphocyte P-glycoprotein.
    Chinn LW; Gow JM; Tse MM; Becker SL; Kroetz DL
    J Antimicrob Chemother; 2007 Jul; 60(1):61-7. PubMed ID: 17510066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between Maraviroc and the ABCB1, ABCG2, and ABCC2 Transporters: An Important Role in Transplacental Pharmacokinetics.
    Tupova L; Ceckova M; Ambrus C; Sorf A; Ptackova Z; Gaborik Z; Staud F
    Drug Metab Dispos; 2019 Sep; 47(9):954-960. PubMed ID: 31266750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to HIV-protease inhibitors selects for increased expression of P-glycoprotein (ABCB1) in Kaposi's sarcoma cells.
    Lucia MB; Anu R; Handley M; Gillet JP; Wu CP; De Donatis GM; Cauda R; Gottesman MM
    Br J Cancer; 2011 Aug; 105(4):513-22. PubMed ID: 21829205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro and In Situ evaluation of pH-dependence of atazanavir intestinal permeability and interactions with acid-reducing agents.
    Kis O; Walmsley SL; Bendayan R
    Pharm Res; 2014 Sep; 31(9):2404-19. PubMed ID: 24595498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro.
    Moss DM; Liptrott NJ; Curley P; Siccardi M; Back DJ; Owen A
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5612-8. PubMed ID: 24002095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of protease inhibitors atazanavir and ritonavir with ABCB1, ABCG2, and ABCC2 transporters: Effect on transplacental disposition in rats.
    Cerveny L; Ptackova Z; Durisova M; Staud F
    Reprod Toxicol; 2018 Aug; 79():57-65. PubMed ID: 29859254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir.
    van Waterschoot RA; ter Heine R; Wagenaar E; van der Kruijssen CM; Rooswinkel RW; Huitema AD; Beijnen JH; Schinkel AH
    Br J Pharmacol; 2010 Jul; 160(5):1224-33. PubMed ID: 20590614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of aged garlic extract on the uptake of saquinavir and darunavir into HepG2 cells and rat liver slices.
    Berginc K; Trontelj J; Kristl A
    Drug Metab Pharmacokinet; 2010; 25(3):307-13. PubMed ID: 20610890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDR1 and BCRP Transporter-Mediated Drug-Drug Interaction between Rilpivirine and Abacavir and Effect on Intestinal Absorption.
    Reznicek J; Ceckova M; Ptackova Z; Martinec O; Tupova L; Cerveny L; Staud F
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells.
    Washington CB; Duran GE; Man MC; Sikic BI; Blaschke TF
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):203-9. PubMed ID: 9803961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines.
    Fujimoto H; Higuchi M; Watanabe H; Koh Y; Ghosh AK; Mitsuya H; Tanoue N; Hamada A; Saito H
    Biol Pharm Bull; 2009 Sep; 32(9):1588-93. PubMed ID: 19721237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of pharmacokinetic enhancement between ritonavir and saquinavir; micro/small dosing tests using midazolam (CYP3A4), fexofenadine (p-glycoprotein), and pravastatin (OATP1B1) as probe drugs.
    Ieiri I; Tsunemitsu S; Maeda K; Ando Y; Izumi N; Kimura M; Yamane N; Okuzono T; Morishita M; Kotani N; Kanda E; Deguchi M; Matsuguma K; Matsuki S; Hirota T; Irie S; Kusuhara H; Sugiyama Y
    J Clin Pharmacol; 2013 Jun; 53(6):654-61. PubMed ID: 23381882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.